Business Context and Reporting Period
This Form 8-K reports on the annual meeting of shareholders held by Zimmer Biomet Holdings, Inc. on May 22, 2026. The filing details the outcomes of four shareholder proposals regarding board elections, auditor ratification, executive compensation, and corporate governance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report on corporate governance events and does not contain financial performance data.
Material Changes and Voting Results
Shareholders took the following actions at the annual meeting:
- Proposal 1 (Election of Directors): All ten (10) nominees were elected to one-year terms. Vote counts ranged from approximately 160.9 million "For" votes (Devdatt Kurdikar) to 167.5 million "For" votes (Louis A. Shapiro).
- Proposal 2 (Auditor Ratification): Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026. The vote was 172.7 million "For" versus 7.9 million "Against".
- Proposal 3 (Executive Compensation): Shareholders approved, on an advisory basis, the compensation of named executive officers. The vote was 160.1 million "For" versus 8.4 million "Against".
- Proposal 4 (Independent Board Chairman): Shareholders rejected a shareholder proposal regarding an Independent Board Chairman. The vote was 31.3 million "For" versus 137.0 million "Against".
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the tabulation of shareholder votes.
Investor Verification Checklist
- Verify the specific terms and responsibilities of the newly elected directors, particularly those with lower "For" vote percentages (e.g., Devdatt Kurdikar and Robert A. Hagemann).
- Review the rationale behind the significant rejection of the Independent Board Chairman proposal to understand shareholder sentiment on governance structure.
- Confirm the engagement letter details with PricewaterhouseCoopers LLP following the ratification vote.
- Check subsequent filings (e.g., 10-K or 10-Q) for the actual financial performance metrics absent from this 8-K.